XML 63 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investments and Derivative Instruments Level 4 Offsetting of Derivative Assets and Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2016
Dec. 31, 2015
Offsetting Derivative Assets [Abstract]    
Derivative Asset, Fair Value, Gross Asset $ 1,394 $ 933
Derivative Asset, Fair Value, Gross Liability 1,139 756
Derivative, Collateral, Obligation to Return Cash [1] (54) (176)
Derivative Asset, Fair Value of Collateral [2] 190 100
Derivative Asset, Fair Value, Amount Offset Against Collateral 65 77
Offsetting Derivative Liabilities [Abstract]    
Derivative Liability, Fair Value, Gross Liability 2,077 1,730
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (1,090) (818)
Derivative, Collateral, Right to Reclaim Cash [3] 5 114
Derivative Liability, Fair Value of Collateral [2] (951) (889)
Derivative Liability, Fair Value, Amount Offset Against Collateral (36) (23)
Other Liabilities [Member]    
Offsetting Derivative Assets [Abstract]    
Derivative Asset, Fair Value, Gross Asset 1,030 524
Offsetting Derivative Liabilities [Abstract]    
Derivative Liability, Fair Value, Gross Liability 2,022 1,322
Other Investments [Member]    
Offsetting Derivative Assets [Abstract]    
Derivative Asset, Fair Value, Gross Asset 364 409
Offsetting Derivative Liabilities [Abstract]    
Derivative Liability, Fair Value, Gross Liability 55 408
Derivative Financial Instruments, Liabilities [Member] | Other Liabilities [Member]    
Offsetting Derivative Assets [Abstract]    
Derivative Assets (Liabilities), at Fair Value, Net [4] (992) (798)
Derivative Financial Instruments, Assets [Member] | Other Investments [Member]    
Offsetting Derivative Assets [Abstract]    
Derivative Assets (Liabilities), at Fair Value, Net [5] $ 309 $ 1 [6]
[1] Included in other assets in the Company's Condensed Consolidated Balance Sheets and amount presented is limited to the net derivative receivable associated with each counterparty.
[2] Excludes collateral associated with exchange-traded derivative instruments
[3] Included in other liabilities in the Company's Condensed Consolidated Balance Sheets and amount presented is limited to the net derivative payable associated with each counterparty.
[4] [4]Approximately $3.2 billion and $1.8 billion of investment sales receivable, as of June 30, 2016, and December 31, 2015, respectively, are excluded from this disclosure requirement because they are trade receivables in the ordinary course of business where the carrying amount approximates fair value. Included in the total fair value amount are $1.0 billion and $1.2 billion of investments, as of June 30, 2016 and December 31, 2015, for which the fair value is estimated using the net asset value per unit as a practical expedient and which are excluded from the disclosure requirement to classify amounts in the fair value hierarchy in connection with the retrospective adoption of ASU 2015-07, Disclosure for Investments in Certain Entities That Calculate Net Asset Value per Share (or its Equivalent), on January 1, 2016.
[5] [1]Included in other investments on the Condensed Consolidated Balance Sheets.
[6] [2]Includes over-the-counter ("OTC") and OTC-cleared derivative instruments in a net positive fair value position after consideration of the accrued interest and impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. See the following footnote 5 for derivative liabilities.